Abstract
HER2 overexpression is correlated with aggressive tumor behavior and poor clinical outcome. Therefore, HER2 has become an important prognostic and predictive factor, as well as a target for molecular therapies. The article reviews recent advances in molecular imaging of HER2 that could facilitate individual approaches to targeted therapy of HER2-positive breast cancers.
| Original language | English |
|---|---|
| Journal | Current Opinion in Oncology |
| Volume | 22 |
| Issue number | 6 |
| Pages (from-to) | 559-66 |
| Number of pages | 8 |
| ISSN | 1040-8746 |
| DOIs | |
| Publication status | Published - 1 Nov 2010 |
Fingerprint
Dive into the research topics of 'Molecular imaging of HER2-positive breast cancer: a step toward an individualized 'image and treat' strategy'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS